IQVIA (IQV) Stock Forecast, Price Target & Predictions
IQV Stock Forecast
IQVIA stock forecast is as follows: an average price target of $266.65 (represents a 39.58% upside from IQV’s last price of $191.04) and a rating consensus of 'Buy', based on 15 wall street analysts offering a 1-year stock forecast.
IQV Price Target
The average price target for IQVIA (IQV) is $266.65 based on 1-year price targets from 15 Wall Street analysts in the past 3 months, with a price target range of $320.00 to $175.38. This represents a potential 39.58% upside from IQV's last price of $191.04.
IQV Analyst Ratings
According to 15 Wall Street analysts, IQVIA's rating consensus is 'Buy'. The analyst rating breakdown for IQV stock is 0 'Strong Buy' (0.00%), 13 'Buy' (86.67%), 2 'Hold' (13.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
IQVIA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 04, 2024 | Jaliendra Singh | Truist Financial | $265.00 | $210.19 | 26.08% | 38.71% |
| Oct 31, 2024 | Elizabeth Anderson | Evercore ISI | $235.00 | $205.82 | 14.18% | 23.01% |
| Oct 29, 2024 | Sean Dodge | RBC Capital | $270.00 | $217.54 | 24.12% | 41.33% |
| Oct 16, 2024 | Justin Bowers | Deutsche Bank | $270.00 | $232.98 | 15.89% | 41.33% |
| Oct 14, 2024 | Jamie Clark | Redburn Partners | $276.00 | $229.26 | 20.39% | 44.47% |
| Sep 20, 2024 | Eric Coldwell | Robert W. Baird | $256.00 | $244.62 | 4.65% | 34.00% |
| Aug 05, 2024 | Jonathan Block | Stifel Nicolaus | $175.38 | $236.24 | -25.76% | -8.20% |
| Jul 23, 2024 | Jailendra Singh | Truist Financial | $300.00 | $240.26 | 24.86% | 57.04% |
| Jul 23, 2024 | Elizabeth Anderson | Evercore ISI | $270.00 | $239.50 | 12.73% | 41.33% |
| Jul 23, 2024 | Luke Sergott | Barclays | $275.00 | $245.23 | 12.14% | 43.95% |
The latest IQVIA stock forecast, released on Nov 04, 2024 by Jaliendra Singh from Truist Financial, set a price target of $265.00, which represents a 26.08% increase from the stock price at the time of the forecast ($210.19), and a 38.71% increase from IQV last price ($191.04).
IQVIA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 3 | 6 | 13 |
| Avg Price Target | $256.67 | $262.00 | $259.88 |
| Last Closing Price | $191.04 | $191.04 | $191.04 |
| Upside/Downside | 34.35% | 37.14% | 36.03% |
In the current month, the average price target of IQVIA stock is $256.67, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 34.35% increase as opposed to IQVIA's last price of $191.04. This month's average price target is down -2.03% compared to last quarter, and down -1.24% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 01, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Nov 01, 2024 | BTIG | Buy | Buy | Hold |
| Oct 29, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Oct 16, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Sep 04, 2024 | RBC Capital | Outperform | Underperform | Initialise |
| Sep 03, 2024 | RBC Capital | - | Outperform | Initialise |
| Jul 24, 2024 | Jefferies | - | Hold | Downgrade |
| Jul 23, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Jul 23, 2024 | UBS | Buy | Buy | Hold |
| Jul 23, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
IQVIA's last stock rating was published by Cowen & Co. on Nov 01, 2024. The company gave IQV a "Buy" rating, the same as its previous rate.
IQVIA Financial Forecast
IQVIA Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.87B | $3.74B | $3.73B | $3.65B | $3.74B | $3.56B | $3.54B | $3.57B | $3.64B | $3.39B | $3.44B | $3.41B | $3.30B | $2.79B |
| Avg Forecast | $4.68B | $4.52B | $4.43B | $4.33B | $4.43B | $4.29B | $4.20B | $4.11B | $4.20B | $4.06B | $3.99B | $3.88B | $3.93B | $3.87B | $3.79B | $3.70B | $3.80B | $3.77B | $3.71B | $3.61B | $3.71B | $3.54B | $3.49B | $3.54B | $3.59B | $3.35B | $3.27B | $3.18B | $3.14B | $2.75B |
| High Forecast | $4.77B | $4.61B | $4.51B | $4.41B | $4.51B | $4.37B | $4.28B | $4.19B | $4.27B | $4.14B | $4.07B | $3.95B | $4.03B | $3.87B | $3.79B | $3.71B | $3.86B | $3.80B | $3.78B | $3.67B | $3.78B | $3.54B | $3.49B | $3.54B | $3.59B | $3.35B | $3.27B | $3.18B | $3.14B | $2.75B |
| Low Forecast | $4.65B | $4.49B | $4.40B | $4.30B | $4.39B | $4.26B | $4.17B | $4.08B | $4.16B | $4.03B | $3.96B | $3.84B | $3.91B | $3.86B | $3.79B | $3.70B | $3.79B | $3.75B | $3.68B | $3.58B | $3.68B | $3.54B | $3.49B | $3.54B | $3.59B | $3.35B | $3.27B | $3.18B | $3.14B | $2.75B |
| # Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 11 | 5 | 5 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.99% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.01% | 1.05% | 1.07% | 1.05% | 1.01% |
IQVIA's average Quarter revenue forecast for Mar 24 based on 4 analysts is $3.70B, with a low forecast of $3.70B, and a high forecast of $3.71B. IQV's average Quarter revenue forecast represents a -4.23% decrease compared to the company's last Quarter revenue of $3.87B (Dec 23).
IQVIA EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 11 | 5 | 5 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $815.00M | $832.00M | $806.00M | $773.00M | $773.00M | $720.00M | $696.00M | $748.00M | $729.00M | $701.00M | $660.00M | $678.00M | $628.00M | $517.00M |
| Avg Forecast | $905.53M | $874.79M | $857.19M | $837.47M | $855.86M | $830.39M | $811.92M | $795.66M | $811.37M | $785.50M | $772.44M | $749.93M | $760.75M | $747.44M | $732.75M | $873.34M | $733.94M | $729.79M | $717.20M | $793.95M | $741.31M | $706.81M | $697.53M | $721.77M | $717.03M | $668.32M | $652.65M | $557.06M | $626.29M | $549.92M |
| High Forecast | $922.05M | $890.74M | $872.82M | $852.74M | $871.47M | $845.53M | $826.73M | $810.17M | $826.16M | $799.83M | $786.53M | $763.43M | $780.06M | $748.60M | $732.75M | $1.05B | $747.33M | $733.96M | $730.28M | $952.74M | $889.57M | $706.81M | $697.53M | $866.13M | $717.03M | $668.32M | $652.65M | $668.47M | $626.29M | $549.92M |
| Low Forecast | $898.34M | $867.84M | $850.38M | $830.82M | $849.06M | $823.79M | $805.47M | $789.34M | $804.92M | $779.27M | $766.31M | $742.22M | $756.89M | $746.28M | $732.75M | $698.68M | $732.01M | $724.68M | $711.50M | $635.16M | $593.05M | $706.81M | $697.53M | $577.42M | $717.03M | $668.32M | $652.65M | $445.65M | $626.29M | $549.92M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.14% | 1.12% | 0.97% | 1.04% | 1.02% | 1.00% | 1.04% | 1.02% | 1.05% | 1.01% | 1.22% | 1.00% | 0.94% |
4 analysts predict IQV's average Quarter EBITDA for Mar 24 to be $873.34M, with a high of $1.05B and a low of $698.68M. This is 7.16% upper than IQVIA's previous annual EBITDA (Dec 23) of $815.00M.
IQVIA Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 11 | 5 | 5 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $469.00M | $303.00M | $297.00M | $289.00M | $227.00M | $283.00M | $256.00M | $325.00M | $317.00M | $261.00M | $175.00M | $212.00M | $119.00M | $101.00M |
| Avg Forecast | $790.22M | $734.96M | $694.43M | $657.59M | $709.79M | $646.71M | $603.72M | $576.72M | $639.94M | $570.72M | $524.07M | $492.49M | $572.99M | $520.23M | $472.42M | $385.12M | $519.69M | $450.13M | $439.28M | $350.11M | $323.37M | $440.58M | $439.35M | $318.29M | $448.68M | $391.24M | $382.26M | $174.18M | $368.91M | $279.53M |
| High Forecast | $808.95M | $752.38M | $710.90M | $673.18M | $726.61M | $662.04M | $618.04M | $590.39M | $655.11M | $584.25M | $536.49M | $520.37M | $580.36M | $521.18M | $472.44M | $462.15M | $523.37M | $459.36M | $449.69M | $420.14M | $388.04M | $440.58M | $439.35M | $381.94M | $448.68M | $391.24M | $382.26M | $209.02M | $368.91M | $279.53M |
| Low Forecast | $782.06M | $727.37M | $687.26M | $650.80M | $702.46M | $640.03M | $597.49M | $570.77M | $633.34M | $564.83M | $518.65M | $473.91M | $567.46M | $519.29M | $472.39M | $308.10M | $516.00M | $433.53M | $434.74M | $280.09M | $258.70M | $440.58M | $439.35M | $254.63M | $448.68M | $391.24M | $382.26M | $139.35M | $368.91M | $279.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.67% | 0.68% | 0.83% | 0.70% | 0.64% | 0.58% | 1.02% | 0.71% | 0.67% | 0.46% | 1.22% | 0.32% | 0.36% |
IQVIA's average Quarter net income forecast for Mar 24 is $385.12M, with a range of $308.10M to $462.15M. IQV's average Quarter net income forecast represents a -17.88% decrease compared to the company's last Quarter net income of $469.00M (Dec 23).
IQVIA SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 11 | 5 | 5 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $556.00M | $502.00M | $482.00M | $513.00M | $583.00M | $517.00M | $483.00M | $488.00M | $542.00M | $498.00M | $482.00M | $442.00M | $491.00M | $460.00M |
| Avg Forecast | $689.50M | $666.09M | $652.69M | $637.67M | $651.68M | $632.28M | $618.22M | $605.84M | $617.80M | $598.11M | $588.16M | $571.02M | $579.26M | $569.12M | $557.94M | $578.28M | $558.85M | $555.68M | $546.10M | $525.71M | $551.15M | $521.15M | $514.31M | $477.92M | $528.68M | $492.77M | $481.22M | $363.16M | $461.78M | $405.47M |
| High Forecast | $702.07M | $678.24M | $664.59M | $649.30M | $663.56M | $643.81M | $629.49M | $616.89M | $629.07M | $609.01M | $598.88M | $581.30M | $593.96M | $570.01M | $557.94M | $693.94M | $569.04M | $558.86M | $556.05M | $630.85M | $661.38M | $521.15M | $514.31M | $573.50M | $528.68M | $492.77M | $481.22M | $435.79M | $461.78M | $405.47M |
| Low Forecast | $684.02M | $660.80M | $647.51M | $632.61M | $646.50M | $627.26M | $613.31M | $601.03M | $612.89M | $593.36M | $583.49M | $565.15M | $576.32M | $568.24M | $557.94M | $462.62M | $557.37M | $551.79M | $541.76M | $420.57M | $440.92M | $521.15M | $514.31M | $382.33M | $528.68M | $492.77M | $481.22M | $290.53M | $461.78M | $405.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.90% | 0.88% | 0.98% | 1.06% | 0.99% | 0.94% | 1.02% | 1.03% | 1.01% | 1.00% | 1.22% | 1.06% | 1.13% |
IQVIA's average Quarter SG&A projection for Mar 24 is $578.28M, based on 4 Wall Street analysts, with a range of $462.62M to $693.94M. The forecast indicates a 4.01% rise compared to IQV last annual SG&A of $556.00M (Dec 23).
IQVIA EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 11 | 5 | 5 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.55 | $1.66 | $1.61 | $1.56 | $1.22 | $1.52 | $1.36 | $1.71 | $1.66 | $1.36 | $0.91 | $1.11 | $0.62 | $0.53 |
| Avg Forecast | $4.29 | $3.99 | $3.77 | $3.57 | $3.85 | $3.51 | $3.28 | $3.13 | $3.47 | $3.10 | $2.85 | $2.67 | $3.11 | $2.82 | $2.56 | $2.49 | $2.82 | $2.44 | $2.38 | $2.41 | $2.76 | $2.39 | $2.38 | $2.42 | $2.43 | $2.12 | $2.07 | $1.86 | $2.00 | $1.52 |
| High Forecast | $4.39 | $4.08 | $3.86 | $3.65 | $3.94 | $3.59 | $3.36 | $3.21 | $3.56 | $3.17 | $2.91 | $2.83 | $3.15 | $2.83 | $2.56 | $2.49 | $2.84 | $2.49 | $2.44 | $2.47 | $2.83 | $2.39 | $2.38 | $2.42 | $2.43 | $2.12 | $2.07 | $1.86 | $2.00 | $1.52 |
| Low Forecast | $4.25 | $3.95 | $3.73 | $3.53 | $3.81 | $3.47 | $3.24 | $3.10 | $3.44 | $3.07 | $2.82 | $2.57 | $3.08 | $2.82 | $2.56 | $2.48 | $2.80 | $2.35 | $2.36 | $2.38 | $2.73 | $2.39 | $2.38 | $2.42 | $2.43 | $2.12 | $2.07 | $1.86 | $2.00 | $1.52 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.68% | 0.68% | 0.65% | 0.44% | 0.64% | 0.57% | 0.71% | 0.68% | 0.64% | 0.44% | 0.60% | 0.31% | 0.35% |
According to 4 Wall Street analysts, IQVIA's projected average Quarter EPS for Mar 24 is $2.49, with a low estimate of $2.48 and a high estimate of $2.49. This represents a -2.43% decrease compared to IQV previous annual EPS of $2.55 (Dec 23).
IQVIA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ICLR | ICON Public Limited Company | $187.22 | $309.60 | 65.37% | Buy |
| CRL | Charles River Laboratories | $187.50 | $303.60 | 61.92% | Buy |
| IQV | IQVIA | $191.04 | $266.65 | 39.58% | Buy |
| MEDP | Medpace | $308.93 | $399.20 | 29.22% | Hold |
| QGEN | Qiagen | $40.99 | $51.89 | 26.59% | Buy |
| LH | Laboratory Corporation of America | $238.64 | $281.25 | 17.86% | Buy |
| RVTY | Revvity | $109.47 | $126.88 | 15.90% | Buy |
| NEOG | Neogen | $15.20 | $17.50 | 15.13% | Buy |
| MTD | Mettler-Toledo | $1.17K | $1.34K | 14.46% | Hold |
| IDXX | IDEXX Laboratories | $419.83 | $479.75 | 14.27% | Buy |
| TWST | Twist Bioscience | $41.43 | $42.40 | 2.34% | Buy |
| WAT | Waters | $355.47 | $356.80 | 0.37% | Buy |